CD38 and COVID-19: Similar to previous research on the Ebola and influenza viruses, the frequency of CD38+HLA-DR+ CD8+ T cells was found to have promptly increased in patients with COVID-19 from day 7 (3.57%) to day 8 (5.32%) and day 9 (11.8%) and then decreased at day 20 (7.05%).